drugset / Trial / NCT00068029
Pegvisomant And Sandostatin LAR Combination Study
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to compare the safety and tolerability of combination therapy with Sandostatin LAR plus Pegvisomant to that of Sandostatin LAR alone or Pegvisomant alone.
Timeline
- Start
- 2003-10
- Primary completion
- —
- Completion
- 2006-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Octreotide | Peptide | — | — |
| Subject | Pegvisomant | Protein / enzyme biologic | — | — |